WhitTier Trust Company’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-54
Closed -$5.49K 1426
2025
Q4
$5.49K Sell
54
-11
-17% -$883 ﹤0.01% 1071
2025
Q3
$3.69K Hold
65
﹤0.01% 1110
2025
Q2
$3.45K Hold
65
﹤0.01% 1256
2025
Q1
$2.81K Hold
65
﹤0.01% 1243
2024
Q4
$3.65K Hold
65
﹤0.01% 1181
2024
Q3
$4.43K Buy
65
+34
+110% +$1.92K ﹤0.01% 1136
2024
Q2
$1.31K Hold
31
﹤0.01% 1196
2024
Q1
$2.14K Hold
31
﹤0.01% 1129
2023
Q4
$2.29K Hold
31
﹤0.01% 1116
2023
Q3
$2.11K Hold
31
﹤0.01% 1075
2023
Q2
$2.91K Hold
31
﹤0.01% 1075
2023
Q1
$2.1K Buy
+31
New +$1.99K ﹤0.01% 1081
2021
Q4
Sell
-200
Closed -$19K 1076
2021
Q3
$19K Buy
+200
New +$21.1K ﹤0.01% 838

Other funds holding EXAS

WhitTier Trust Company's EXAS Position: Q1 2026 in Review

WhitTier Trust Company sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 54 shares — an estimated $5.49K sold.

WhitTier Trust Company first reported a position in EXAS in Q3 2021 and held it in 13 quarters. The position peaked at $19K in Q3 2021. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

  • WhitTier Trust Company reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
  • WhitTier Trust Company sold 54 Exact Sciences shares in Q1 2026, an estimated $5.49K.
  • WhitTier Trust Company first reported a position in Exact Sciences in Q3 2021 and held it in 13 quarters.
  • WhitTier Trust Company's Exact Sciences position peaked at $19K in Q3 2021.
  • 7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on WhitTier Trust Company's 13F filing for Q1 2026, filed 28 Apr 2026.